Article Details

Centrexion raises $67 million to take lead therapy into Phase III

Retrieved on: 2018-01-02 21:40:06

Tags for this article:

Click the tags to see associated articles and topics

Centrexion raises $67 million to take lead therapy into Phase III. View article details on hiswai:

Excerpt

<div><b>New Enterprise Associates</b> (NEA) led the financing with strong participation from new and existing investors, including Quan Capital, ArrowMark Partners, 6 Dimensions Capital, and Efung Capital. OA is a rapidly escalating public health issue that is projected to affect nearly 67 million Americans by 2030 ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up